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Abstract  
Aims: To determine population-related and technical sources of variation in cardiac magnetic 
resonance (CMR) reference ranges for left ventricular (LV) quantification through a formal 
systematic review and meta-analysis.  
 
Methods and results: This study is registered with the International Prospective Register of 
Systematic Reviews (CRD42019147161). Relevant studies were identified through electronic 
searches and assessed by two independent reviewers based on predefined criteria. Fifteen studies 
comprising 2,132 women and 1,890 men aged 20–91years are included in the analysis. Pooled LV 
reference ranges calculated using random effects meta-analysis with inverse variance weighting 
revealed significant differences by age, sex, and ethnicity. Men had larger LV volumes and higher LV 
mass than women [LV end-diastolic volume (mean difference=6.1ml/m2, p-value=0.014), LV end-
systolic volume (MD=4ml/m2, p-value=0.033), LV mass (mean difference=12g/m2, p-value=7.8×10-
9)]. Younger individuals had larger LV end-diastolic volumes than older ages (20-40years vs ≥
 65years: women MD=14.0ml/m2, men MD=14.7ml/m2). East Asians (Chinese, Korean, Singaporean-
Chinese, n=514) had lower LV mass than Caucasians (women: MD=6.4g/m2, p-value=0.016; men: 
MD=9.8g/m2, p-value=6.7 ×10-5). Between study heterogeneity was high for all LV parameters 
despite stratification by population-related factors. Sensitivity analyses identified differences in 
contouring methodology, magnet strength, and post-processing software as potential sources of 
heterogeneity.  
 
Conclusion: There is significant variation between CMR normal reference ranges due to multiple 
population-related and technical factors. Whilst there is need for population stratified reference 
ranges, limited sample sizes and technical heterogeneity precludes derivation of meaningful unified 
ranges from existing reports. Wider representation of different populations and standardisation of 
image analysis is urgently needed to establish such reference distributions.   
 
Keywords: Cardiac magnetic resonance, reference range, normal range, left ventricle 
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Introduction  
Accurate quantification of left ventricular (LV) structure and function is key to clinical decision 
making in cardiology. LV cavity volumes in end-systole (LVESV) and end-diastole (LVEDV) reflect 
adverse myocardial remodelling1. LV mass (LVM), is an independent prognostic marker in 
individuals with and without cardiovascular disease2–4. LV ejection fraction (LVEF) provides an 
estimate of LV systolic function and is the determinant of many important clinical decisions such as 
cardiac-resynchronisation therapy, valve interventions, and management of heart failure syndromes5–9.  
 
Cardiac magnetic resonance (CMR) is the reference test for cardiac chamber quantification and is 
increasingly used to guide difficult clinical decisions. However, there is lack of consensus on normal 
reference ranges with variation in published reports10. Whilst there are known sex, age, and ethnic 
differences in cardiac morphology11–13, these differences have not been adequately studied with CMR 
and commonly quoted ranges are based on small cohorts that do not always represent the populations 
to which they are applied.  
 
Previous attempts to pool results from different CMR reference ranges were limited by the datasets 
available at the time, with small sample sizes, inability to provide age and ethnicity stratification, or 
perform a formal meta-analysis14. In the last five years, there has been a surge of publications 
reporting normal CMR reference ranges from around the world. The objective of this study is to 
determine population-related (sex, age, ethnicity) and technical sources of heterogeneity through a 
formal systematic review and meta-analysis of published CMR reference ranges.  
 
Methods 
This study is registered online with the International Prospective Register of Systematic Reviews 
(PROSPERO, https://www.crd.york.ac.uk/PROSPERO/; registration number: CRD42019147161). 
Methods are in accordance with the PRISMA statement (Transparent Reporting of Systematic 
Reviews and Meta-Analyses, http://prisma-statement.org/). The PRISMA checklist is provided in the 
Supplementary material.  
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Selection criteria 
We selected studies that defined a normal reference range in healthy adults (>18years-old) with 
sample sizes of ≥50, reported in the English language. We required confirmation of healthy status of 
participants, however we allowed some variation in the stringency with which this was defined. We 
accepted studies with 1.5T or 3T scanners from all vendors. We restricted to studies using steady state 
free precession (SSFP) sequences, as this reflects current clinical standards for volume quantification. 
We required LV quantification to be made using short axis cine images using a predefined standard 
operating procedure for image acquisition and analysis. Studies selected for quantitative analysis were 
required to report sex stratified LVM, LVEDV, LVESV, and LVEF in a manner where mean and 
standard deviation values in indexed formats [indexed to body surface area (BSA), denoted by i] 
could be extracted. 
 
Search strategy  
ZRE and AK independently searched Ovid Medline (1946- April 2019) and Embase electronic 
databases. Relevant subject headings were used to conduct the search using MeSH terms (Medical 
Subject Headings) for Medline and the equivalent, Emtree, for Embase. Subject headings and their 
‘trees’ were examined, and relevant subheadings were selected, related terms were included using the 
explode command (Supplementary Table 2). Search terms were combined using Boolean operators. 
Selected terms were included in the search as keywords. We performed separate keyword search of 
titles and abstracts to ensure capture of newer publications not yet incorporated into MeSH/Emtree 
classifications. The final output was limited to studies in adults (>18years-old) and in the English 
language.  
 
Study selection 
Study selection was through a process of title screening, abstract review, and full text review carried 
out independently by AK and ZRE. At each iteration, results were merged, and duplicates removed. 
Further studies were identified through reference and author searching. Decision for study eligibility 
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was based on predefined selection criteria. In case of disagreement, decisions were taken through 
discussion after review of full text and mediation by MYK. 
 
Quality assessment  
As this review was not based on intervention-outcome studies, existing quality assessment tools were 
not entirely applicable. We therefore designed a quality assessment protocol tailored to our purpose 
based on revised elements from the ROBINS-I (The Risk Of Bias In Non-randomized Studies – of 
Interventions) and QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) assessment 
tools15,16. 
 
Data extraction 
Mean, standard deviation, and sample size for sex stratified LVMi, LVESVi, LVEDVi, and LVEF 
were extracted from individual studies. Data extraction was carried out independently by ZRE and 
AK and cross-checked by ZRE. 
 
Statistical analysis 
Statistical analysis was with the ‘meta: General package for meta-analysis’ package on the R studio 
platform [R Core Team (2018). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/]17. We 
calculated pooled age, sex, and ethnicity specific ranges for LV parameters indexed to BSA. We used 
random effects meta-analysis of single means with inverse variance weighting to calculate pooled 
values. Between study heterogeneity was assessed with 𝜏2, I2, Q statistic, and the related p-value. For 
subgroup analysis, mean difference (MD), Q statistic, and p-values are presented. We performed 
sensitivity analysis with the following variables: scanner vendor, magnet strength, post-processing 
analysis software, papillary muscles contouring (inclusion/exclusion in LVM). To assess the impact 
of the larger studies in the meta-analysis on the overall results we display results for both fixed and 
random effects models in the figures. A large study with extreme results would lose influence under 
the random effects model. Our analyses demonstrate similar estimates from fixed and random effects 
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models; therefore we conclude that variations in study sample size are not having a disproportionate 
impact on the results. For further illustration we performed sensitivity analysis with exclusion of the 
two largest studies from the pooled estimates, which also did not significantly alter the pooled 
estimates. 
 
Results 
Systematic review 
Our approach is summarised in the PRISMA flow diagram (Figure 1). Combined Ovid Medline and 
Embase searches yielded 859 unique hits; 6 additional citations were obtained from cross-referencing 
and author searches. After title screening, 112 citations were deemed potentially relevant and selected 
for abstract review. From these, 27 papers were selected for full text review based on fulfilment of the 
inclusion criteria. A further 12 studies were excluded after examination of the full text based on 
quality assessment and consideration of inclusion criteria. Fifteen studies were selected for inclusion 
in the meta-analysis. Of these, two did not report LVESV, therefore, 13 studies are included in 
analysis for this parameter. 
 
Quality assessment  
Pertinent quality indicators were systematically assessed for studies selected for full text review. 
There were differences in the definition of “healthy status” with variable use of clinical assessment, 
blood tests, and non-invasive tests (echocardiography, electrocardiogram) to exclude disease. There 
were also variations in the number of readers and reports of inter-/intra-observer variability. Overall, 
the studies included in the meta-analysis are of high quality with clearly defined study objectives and 
imaging protocols (Supplementary Table 1). 
 
Summary of selected studies  
Overall 2,132 women and 1,890 men from 15 studies published between 2003-2018 are included in 
the analysis (Table 1). The age range is between 20-91years. There are five studies from non-
Caucasian cohorts: two from Chinese populations18,19, and one study each from Singaporean-
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Chinese20, Korean21, and Brazilian22 cohorts. There are ten studies from Caucasian populations23–30. 
Both the Chinese studies and the study from Singapore use a 3T scanner, all others use 1.5T scanners. 
Scanners used included several Siemens and Philips models; one of the earlier studies used a General 
Electric (GE) scanner. Various versions of a wide range of post-processing software packages were 
used for endocardial contouring. Contouring technique was either manual or semi-automated with 
manual edits. Eleven studies included papillary muscles in the LVM, the remainder as part of the 
blood pool. 
 
Meta-analysis 
Stratification by sex 
Results for sex-stratified analyses are summarised in Table 2, Figure 2, and Figure 3. Compared to 
women, men had significantly larger LVEDVi (MD=6.1ml/m2, p-value=0.014), LVESVi 
(MD=4.0ml/m2, p-value=0.033), and LVMi (MD=12.0 g/m2, p-value=7.8×10-9). LVEF was not 
significantly different between men and women (MD=-1.5%, p-value 0.33). In both men and women, 
there was significant between-study heterogeneity for all LV parameters (I2 >97% for all).  
 
Stratification by age and sex 
Three age categories were created to represent young (20-40 years), middle aged (40-65 years), and 
older (≥65 years) adults. These age cut-offs allowed inclusion of the largest possible pooled sample 
from all studies. Age and sex stratified results are presented in Supplementary Table 3. Both men and 
women had significantly larger LVEDVi in younger age (Supplementary Figure 1) with similar 
magnitude of difference (20-40 years vs ≥ 65years: women MD=14.0 ml/m2, men MD=14.7 ml/m2). 
A trend for larger LVESVi in younger age is observed for both men and women, but is not 
statistically significant in either. There were non-significant trends towards greater LVMi in younger 
and higher LVEF in older individuals. The data available did not permit analysis with age as a 
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continuous measure or with more granular age bands. Between-study heterogeneity remained high 
after sex and age stratification. 
 
Stratification by sex and ethnicity 
Pooled values were calculated for two ethnicity categories: East Asian (Chinese, Singaporean-
Chinese, Korean) and Caucasian (including non-Aboriginal Australian). East Asian men and women 
had significantly lower LVMi compared to Caucasians (women: MD=6.4g/m2, p-value=0.016; men: 
MD=9.8g/m2, p-value=6.7 ×10-5), this difference was more consistent and of greater magnitude in 
men (Supplementary Figure 2). Again, there was high statistical heterogeneity between studies. 
Further comparison was made between pooled values for Caucasians, East Asians, and the one 
Brazilian cohort. Again, significant subgroup differences were observed in LVMi for both men and 
women. Brazilian men and women had greater LVMi than East Asians, but lower values than 
Caucasians. There were no significant ethnic differences in any of the other LV parameters 
(Supplementary Table 4). We present pooled sex stratified results for Caucasians and East Asians 
with addition of age stratification for Caucasians (Figure 4, Figure 5). We cannot provide pooled age 
and sex stratified results for East Asians due to variation in age bands and reporting of stratified 
results in the original studies.  
 
Sensitivity analyses 
To explore other potential sources of between-study heterogeneity, sensitivity analyses were 
performed with the following variables: scanner vendor, field strength, post-processing software, and 
papillary muscle contouring (included vs excluded from LVM) (Supplementary Table 5). Studies 
including papillary muscles as part of the LVM reported significantly higher LVM for both men 
(MD=7.1g/m2, p-value=0.017) and women (MD=6.0g/m2, p-value=0.029). Despite stratification for 
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sex and contouring methodology, heterogeneity between studies remained high, with greater 
heterogeneity for studies contouring papillary muscles as part of LVM (Supplementary Figure 3). The 
post-processing software used for contouring also impacted results with Argus software from Siemens 
Medical yielding significantly smaller LVESVi and higher LVMi in comparison to other post-
processing tools. We also note a significant relationship between lower LVMi and 3T field strength 
scanners. Limited samples and significant methodological heterogeneity at all levels meant that 
pooling of results with stratification for multiple technical and population related factors was not 
possible.  
 
Discussion 
Summary of findings 
We present the first formal systematic review and meta-analysis of CMR normal reference ranges 
incorporating results from 1,890 men and 2,132 women from 15 studies. Pooled results demonstrate 
significant differences in LV parameters by sex, age, and ethnicity. Compared to women, men had 
larger cavity volumes and greater LVMi. Younger individuals had larger LV volumes, higher LVMi 
and lower LVEF in comparison to older ages. Individuals with East Asian ancestry had lower LVMi 
in comparison to Caucasians. Between-study heterogeneity was high for all parameters despite 
stratification for population-related factors. Sensitivity analyses identified differences in contouring 
methodology, post-processing software, and magnet field strength as significant contributors to the 
observed between-study heterogeneity. Limited sample sizes from existing results and methodological 
variation at all levels precludes recommendation of robust unified reference ranges from this analysis. 
 
Comparison with previous literature 
The observed sex, age, and ethnic differences in LV measures are consistent with previous reports 
using cardiac computed tomography, echocardiography, and gradient echo CMR31–35. 
Echocardiography studies report important differences in cardiac morphology of healthy individuals 
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of South Asian and Afro-Caribbean ethnicity in comparison to Caucasians32,36,37. Further, there are 
reports of differential impact of alterations in LV parameters in different ethnic populations. For 
instance, Akintoye et al. report greater prognostic utility of LVMi for predicting cardiovascular events 
for Chinese and Hispanic populations in comparison to non-Hispanic Whites38. Similarly, there are 
reports of significant ethnic differences in ventricular remodelling in response to important 
cardiovascular risk factors such as hypertension36. As ethnic differences exist for LV parameters, it is 
likely that there are also ethnic differences in the morphology of other cardiac structures such as the 
right ventricle and the atria. Whilst in recent years, there have been reports of CMR references ranges 
from several non-Caucasian cohorts, data from a wide range of ethnicities remains absent, as such, 
our understanding of ethnic differences in CMR derived measures of cardiac morphology remains 
incomplete.  
 
In addition to the expected variations by population-related factors, we identified important technical 
sources of heterogeneity. We identified magnet strength (3T vs 1.5) as a significant source of 
variation, in particular lower LVMi reported by the studies using 3T scanners. Certainly, it is 
conceivable that higher spatial resolution produced by expert programming of pulse sequences with 
3T scanners provides superior endocardial border definition and thus more accurate contouring of the 
LV endocardium with exclusion of an intracavity trabecular layer that may be included within LVM 
at lower spatial resolutions. However, there are other factors that need consideration, for instance, the 
3T studies are all more recent publications (2016 onwards) and image analysis for these studies has 
been conducted with modern post-processing software allowing for more accurate border contouring 
in comparison to older studies. There are also important population differences- all the studies with 
3T scanners are from East Asian cohorts, whereas all studies on Caucasians are with 1.5T scanners.  
With the presence of multiple overlapping variables, it is impossible to isolate definitively the effect 
of 3T vs 1.5T in this study. Previous studies dedicated to comparison of LV measures at 3T vs 1.5T 
have not shown significant differences between the two39.  On balance, our judgement is that the 
observed differences are more likely related to ethnic differences with perhaps a smaller contribution 
from the various technical sources of variation. 
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Consistent with previous reports, we identified differences in endocardial contouring as a significant 
source of variation40,41. There was greater heterogeneity between studies that included papillary 
muscles within LVM compared to those that did not, perhaps reflecting difficulties in reproducibly 
tracing the irregular geometry of papillary muscles. Previous studies report similar variations with the 
potential for clinically important differences in the assessment of relevant pathologies such as 
hypertrophic cardiomyopathy and Fabry’s disease42,43. Whilst other sources of technical variation do 
exist and perhaps have a cumulative effect, it does seem that contouring technique is the most 
important. Interestingly, a small study of variation of CMR derived LV measures from the use of 
different software packages demonstrated no significant variation from the software programmes with 
the application of a standardised contouring protocol and a single scanner vendor 44. This observation 
suggests that the variability in LV quantification measures may be eliminated, or certainly reduced, by 
development of uniform contouring practices.  
 
Our analysis suggests that the high between-study heterogeneity is a result of cumulative effects from 
multiple population-related and technical sources of variation. We were unable to significantly reduce 
between-study heterogeneity through stratification by one or two factors and the sample size does not 
permit meaningful sub-analysis by greater number of variables. 
 
Relevance for clinical practice  
Our results show that for both men and women, healthy young adults have on average 21% larger 
LVEDVi compared to healthy older adults (age <40years vs age >65years: women MD= 14.0ml/m2, 
max difference= 24.3ml/m2; men MD= 14.7 ml/m2, max difference= 26.0 ml/m2). Whilst specific 
recommendations for age-correction cannot be made, reporting cardiologists should consider this 
level of variation when applying reference ranges to individuals outside represented age groups. 
Similar considerations should be made regarding ethnicity. Our findings show lower LVMi in East 
Asians compared to Caucasians with mean percentage difference of 18% and 15% in men and women 
respectively (women: MD= 6.4g/m2, max difference= 13.7g/m2; men: MD=9.8g/m2, max difference= 
16.4g/m2). These differences can be clinically important. For example, consider an East Asian man 
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with LVMi of 63g/m2 – whilst this is average for a Caucasian population, it is well above the upper 
limit of normal for Asian cohorts (56.2g/m2). Where possible, ethnicity-specific reference ranges 
should be used. Differences produced by technical factors, in particular, contouring methodology 
should also be considered. For instance, our findings suggest approximately 13% greater LVMi for 
both men and women when contouring includes papillary muscles within LVM.  
 
Whilst CMR remains the references standard for LV quantification, the results must be interpreted 
with consideration of age, sex, and ethnic differences. In addition, there are multiple technical sources 
of variation that may result in clinically important differences in reported values. Considering the high 
statistical heterogeneity between studies and the importance of technical sources of variation, we 
would recommend use of reference ranges that most resembles one’s own clinical practice in terms of 
image acquisition, analysis, and population. In cases of variation in practice from the reference range 
of choice, it is possible to making approximate corrections using the calculations provided here.  
 
Directions for future work 
This work highlights the need for richer reference datasets with attention to incorporation of data from 
different ethnic groups and wider spectrum of ages. The lack of published data from ethnicities with 
known important differences in cardiac morphology, in particular African populations, is a significant 
limitation of existing literature. We should aim for development of reference ranges that are fully 
stratified by age, sex, and ethnicity. It is also important that we reduce the level of heterogeneity 
introduced by technical factors, with development of a unified approach to contouring methodology 
being a key step. However, it is difficult to make consensus recommendations at present, as it is not 
clear from existing literature, which contouring method best predicts clinical outcomes and/or 
discriminates disease. Therefore, prior to embarking on development of standardised approaches, 
research is needed into the prognostic and diagnostic value of different contouring methodologies. 
Finally, consideration of variability in cardiac morphometrics beyond traditional CMR indices is 
important for better understanding of differential disease patterns and risk profiles in different 
populations and would allow for deeper phenotyping of individuals and their disease susceptibilities. 
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Limitations  
Our search strategy was thorough for published reports of CMR normal reference ranges; however, 
we did not seek results from unpublished cohorts. Whilst this may have resulted in a larger sample 
size, quality control of data that has not been through a formal peer review process is challenging and 
inclusion of such data may have compromised the quality of the study. There are important gaps in 
the literature with paucity of data for individuals in the youngest and oldest age categories and limited 
representation of non-Caucasian ethnicities. Our analysis reflects these gaps in published data. Whilst 
age, sex, and ethnicity explain part of the between-study heterogeneity, there are technical sources of 
variation that cannot be fully explored within the scope of this study (Figure 4). 
 
Conclusions  
There is significant heterogeneity in published CMR LV reference ranges. Age, sex, and ethnicity 
represent significant sources of variation and we should endeavour to develop reference ranges 
stratified to these parameters. Different endocardial contouring methodology, scanner magnet 
strength, and post-processing software all contribute to the observed variability. Due to multiple 
sources of heterogeneity, it is not possible to produce reliable normal ranges across a wide age range, 
by sex or ethnicity from existing reports. Wider representation of different populations and 
standardisation of image analysis is urgently needed to establish such reference distributions, and thus 
ensure global comparability of CMR measures. 
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Table 1. Summary of studies selected for inclusion in the meta-analysis 
 LVM: left ventricular mass; T: Tesla; n denotes total sample size available for analysis. *Age: range, or mean (years) 
 
Author, year of 
publication 
 
Single/Multi-
centre  
Sample size, 
Male:Female 
Age* Ethnicity Scanner vendor Field 
strength 
(T) 
Analysis software Contouring 
technique 
Papillary muscle 
included/excluded 
from LVM 
Bulow et al.23, 
2018 
Single n=617 
291:326 
Men (43) 
Women (45) 
Caucasian Siemens Magnetom 1.5 QMass MR, Medis Manual Included 
Lei et al.19, 2017 
 
Single n=120 
60: 60 
20 – 83 Chinese Siemens Magnetom 3 QMass MR, Medis Manual Excluded 
Petersen et al.24, 
2017 
Single n=800 
368:432 
45 – 74 Caucasian Siemens Magnetom 1.5 CMR42, Circle 
Cardiovascular Imaging 
Manual Excluded 
Aquaro et al.25, 
2017 
Multi n=255 
140:115 
15 – 80 Caucasian Multi-vendor 1.5 Multiple 
 
Manual Included 
Le et al.20, 2016 
 
Single n=180 
91:89 
20 – 69 Singaporean-
Chinese 
Philips Ingenia 3 CMR42, Circle 
Cardiovascular Imaging 
Not stated Included 
Li et al.18, 2016 
 
Single n=90 
45:45 
40 – 65 Chinese Philips Achieva 3 Philips Medical Systems, 
Philips 
Manual Included 
Le Ven et al.26, 
2016 
Single n=434 
196:238 
18 – 35 Caucasian Philips Achieva 1.5 CMR42, Circle 
Cardiovascular Imaging 
Semi-automated Included 
Yeon et al.27, 
2015 
Single n=852 
340:512 
Men (61) 
Women (62) 
Caucasian Philips Gyroscan 
 
1.5 EasyVision 5.1, Philips Manual Excluded 
Macedo et al.22, 
2013 
Multi n=107 
54:53 
20 – 80 Brazilian Philips Achieva 1.5  Multiple Semi-automated Included 
Chang et al.21, 
2012 
Single n=124 
64:60 
20-70 Korean 
 
Siemens Magnetom 1.5 Argus, Siemens Manual Excluded 
Teo et al.28, 2008 
 
Single n=60 
41:19 
51 Non-aboriginal 
Australian 
(Caucasian) 
Siemens Sonata 1.5 Argus, Siemens Manual Included 
Maceira et al.29, 
2006 
Single n=120 
60:60 
20 – 80 Caucasian Siemens Sonata 1.5 CMRtools, 
Cardiovascular Imaging 
Solutions 
Semi-automated Included 
Nikitin et al.47, 
2006 
Single n=95 
47:48 
22 – 91 Caucasian General Electric 
SignaCV/i 
1.5 
 
MRI-MASS, Medis Semi-automated 
 
Included 
Hudsmith et al.30, 
2005 
Single n=108 
63:45 
21- 68 Caucasian Siemens Sonata 1.5 Argus, Siemens Manual Included 
Alfakih et al.48, 
2003 
Single n=60 
30:30 
20 – 65 Caucasian Philips Intera 1.5 MRI-MASS, Medis Manual Included 
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Table 2. Pooled mean left ventricular parameters with sex stratification and expression of between-study and subgroup heterogeneity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Between study heterogeneity Subgroup differences (men vs women) 
  Mean (95% CI) Q statistic 𝜏2 I2 p-value Mean difference Q statistic p-value 
LVEDVi 
(ml/m2) 
Men 77.4 (73.7 – 81.1) 655.38 51.1 97.9% 8.5 ×10-131 6.1 5.99 0.014 
Women 71.3 (68.1 – 74.5) 736.42 36.6 98.1% 4.3×10-148 
LVESVi 
(ml/m2) 
Men 28.4 (25.4 – 31.3) 1196.4 29.1 99.0% 1.03×10-248 4.0 4.52 0.033 
Women  24.4  (22.3 – 26.5) 933.7 14.3 98.7% 3.3 ×10-192  
LVMi 
(g/m2) 
Men 60.5 (57.3 – 63.7) 773.88 18.2 98.2% 4.3×10-156 12 33.32 7.8×10-9 
Women  48.5 (45.9 – 51.0) 942.39 24.7 98.5% 3.5×10-192 
LVEF 
(%)  
Men 63.8 (61.6 – 66.1) 1272.22 19.2 98.9% 5.1×10-263 -1.5 0.95 0.33 
Women 65.3 (63.5 – 67.1) 960.15 12.1 98.5% 5.5×10-196 
CI: confidence interval; LVEDVi: left ventricular end-diastolic volume indexed to body surface area; LVESVi: left ventricular end-systolic volume 
indexed to body surface area; LVMi: left ventricular mass indexed to body surface area; LVEF: left ventricular ejection fraction. Significance level 
is set at p-value < 0.05. Random effects model is used for assessment of subgroups and between-study heterogeneity. 
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Figure 1. Flow diagram summarising flow of information through different phases of the systematic review 
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Figure 2. Forest plots of left ventricular parameters indexed to body surface area for women* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI: confidence interval; LVEDVi: left ventricular end diastolic volume indexed to body surface area (ml/m2); LVESVi: left ventricular end systolic volume indexed to body surface area (ml/m2); 
LVMi: left ventricular mass indexed to body surface area (g/m2); LVEF: left ventricular ejection fraction (%). Both fixed effect and random effects estimates are presented. The vertical 
reference line corresponds to random effects pooled mean estimate.    
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
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Figure 3. Forest plots of left ventricular parameters indexed to body surface area for men* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI: confidence interval; LVEDVi: left ventricular end diastolic volume indexed to body surface area (ml/m2); LVESVi: left ventricular end systolic volume indexed to body surface area (ml/m2); 
LVMi: left ventricular mass indexed to body surface area (g/m2); LVEF: left ventricular ejection fraction (%). Both fixed effect and random effects estimates are presented. The vertical 
reference line corresponds to random effects pooled mean estimate.       
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
Total (fixed effect) 
Total (random effects) 
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Figure 4. Potential sources of variability in cardiac magnetic resonance measurements 
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Image acquisition 
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o Sequence parameters: TE, TR, flip 
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o Prospective/retrospective gating 
o Variability in positioning cut planes 
Scanner 
o Vendor 
o Field strength 
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o Normal haemodynamic variations: 
fluid status, blood pressure, heart rate 
  
Post-processing 
o Software vendor and version 
o Contouring method (manual, 
semi-automated, fully 
automated) 
o Inclusion/exclusion of papillary 
muscles in LVM 
  
SSFP: steady state free precession; FOV: field of view; GE: gradient echo; LVM: left ventricular mass; SE: spin echo; TE: echo time; TR: 
repetition time 
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Figure 5. Pooled mean (95% CI) left ventricular parameters for  men, stratified by age and 
ethnicity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LVEDVi: left ventricular end-diastolic volume indexed to body surface area (ml/m2); LVESVi: left 
ventricular end-systolic volume indexed to body surface area (ml/m2); LVEF: left ventricular ejection 
fraction (%); LVMi: left ventricular mass indexed to body surface area (g/m2). Results are pooled 
random effects means with corresponding 95% confidence intervals (CI).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Caucasian 
LVEDVi: 78.4ml/m2 (73.5–83.2) 
LVESVi: 29.1ml/m2 (25.2–33.0) 
LVMi: 63.4g/m2 (59.3–67.4)   
LVEF: 63.8% (60.9–66.7) 
20-40 years-old 
LVEDVi: 88.4ml/m2 (85.8–90.9) 
LVESVi: 33.7ml/m2 (29.5–38.0) 
LVMi:67.3g/m2 (60.1–74.5)  
LVEF: 62.7% (57.8–67.5) 
40-65 years-old 
LVEDVi: 79.8ml/m2 (73.5–86.2) 
LVESVi: 30.6ml/m2 (24.7–36.5) 
LVMi: 63.0g/m2 (57.1–69.0) 
LVEF: 62.5% (58.6–66.5) 
>65 years-old 
LVEDVi: 71.4ml/m2 (63.3–79.5) 
LVESVi: 26.0ml/m2 (19.4–32.5) 
LVMi: 59.8g/m2 (53.0–66.7) 
LVEF: 64.5% (59.0–70.0) 
East Asian 
LVEDVi: 75.6ml/m2 (71.5–79.7) 
LVESVi: 27.4ml/m2 (23.0–31.9) 
LVMi: 53.6g/m2 (51.0–56.2)   
LVEF: 63.6% (59.3–67.9) 
n=1,576 n=260 
LVEDV: Left ventricular end-diastolic volume 
LVESV: Left ventricular end-systolic volume 
LVM: Left ventricular mass 
LVEF: Left ventricular ejection fraction  
i denotes indexation to bsa 
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Figure 6. Pooled mean (95% CI) left ventricular parameters for  women, stratified by age and 
ethnicity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LVEDVi: left ventricular end-diastolic volume indexed to body surface area (ml/m2); LVESVi: left 
ventricular end-systolic volume indexed to body surface area (ml/m2); LVEF: left ventricular ejection 
fraction (%); LVMi: left ventricular mass indexed to body surface area (g/m2). Results are pooled 
random effects means with corresponding 95% confidence intervals (CI).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Caucasian 
LVEDVi: 71.7ml/m2 (67.2–76.2) 
LVESVi: 24.5ml/m2 (21.4– 27.7) 
LVMi: 50.6g/m2 (47.2–54.0) 
LVEF: 65.0% (62.5–67.5) 
20-40 years-old 
LVEDVi: 80.5ml/m2 (78.4–82.6) 
LVESVi: 28.6ml/m2 (25.5–31.8) 
LVMi: 53.7g/m2 (46.3–61.0) 
LVEF: 64.4% (60.5–68.3) 
40-65 years-old 
LVEDVi: 70.8ml/m2 (64.7–77.0) 
LVESVi: 25.9ml/m2 (20.9–31.0) 
LVMi: 46.4g/m2 (42.9–50.3) 
LVEF: 63.5% (59.8–67.2) 
>65 years-old 
LVEDVi: 65.0ml/m2 (57.9–72.1) 
LVESVi: 22.0ml/m2 (16.1–28.0) 
LVMi: 49.2g/m2 (42.5–55.9) 
LVEF: 66.6% (61.1–72.2%) 
East Asian 
LVEDVi: 70.8ml/m2 (69.6–72.0) 
LVESVi: 24.2ml/m2 (22.5–26.0) 
LVMi: 44.2g/m2 (40.3–48.1) 
LVEF: 65.6% (63.0–68.2) 
n=1,825 n=254 
LVEDV: Left ventricular end-diastolic volume 
LVESV: Left ventricular end-systolic volume 
LVM: Left ventricular mass 
LVEF: Left ventricular ejection fraction  
i denotes indexation to bsa 
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LVEDVi: left ventricular end diastolic volume indexed to body surface area (ml/m2); LVESVi: left ventricular end systolic volume indexed to body surface area (ml/m2); LVMi: left ventricular 
mass indexed to body surface area (g/m2); LVEF: left ventricular ejection fraction (%); MD: mean difference. In Panel B, MD refers to 20-40 years vs >65 years. In Panel C, Asian refers to 
Chinese, Singaporean-Chinese, and Korean. Displayed values are pooled random effects means from meta-analysis. Error bars correspond to 95% confidence intervals. P-value corresponds to test 
of heterogeneity between subgroups. 
Central Illustration. Panel A: Sex stratified left ventricular parameters; Panel B: Age and sex stratified LVEDVi; Panel C: Ethnicity and sex stratified LVMi 
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Supplementary Figure 1. Forest plots of age and sex stratified left ventricular end diastolic volume indexed to body surface area 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI: confidence interval; LVEDVi: left ventricular end diastolic volume indexed to body surface area (ml/m2); The vertical reference line corresponds to random effects 
pooled mean estimate for men and women without age stratification. Vertical reference line corresponds to the pooled random effects mean for men and women without other 
stratification      
 30 
 
Supplementary Figure 2. Forest plots of sex and ethnicity stratified left ventricular mass indexed to body surface area 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI: confidence interval; LVMi: left ventricular end diastolic mass indexed to body surface area (g/m2); The vertical reference line corresponds to random effects pooled 
mean estimate for men and women without other stratification. Vertical reference line corresponds to the pooled random effects mean for men and women without other 
stratification.  
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Supplementary Figure 3. Forest plots of left ventricular mass indexed to body surface area stratified by sex and papillary muscle inclusion/exclusion in left 
ventricular mass 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI: confidence interval; LVMi: left ventricular end diastolic mass indexed to body surface area (g/m2); The vertical reference line corresponds to random effects pooled 
mean estimate for men and women without other stratification. Papillary_muscle = include indicates inclusion of papillary muscle in LVMi, papillary_muscle=exclude 
indicates exclusion of papillary muscles from LVMi.  
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Supplementary Table 1. Medline search strategy 
 Search terms Results 
(n) 
1 exp heart ventricles/ or exp myocardium/ 245485 
2 exp cardiac volume/ or exp ventricular function, left/ or exp ventricular function, 
right/ 
44207 
3 1 or 2  276474 
4 exp Magnetic Resonance Imaging/mt, st, sn [Methods, Standards, Statistics & 
Numerical Data] 
122759 
5 exp Reference Values/ 156703 
6 normal.mp. 1448341 
7  healthy.mp. or exp Healthy Volunteers/ 671578 
8 5 or 6 or 7  2094950 
9 3 and 4 and 8  1159 
10 limit 9 to (English language and humans and "all adult (19 plus years)") 778 
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Supplementary Table 2. Quality assessment of studies included in the meta-analysis 
     Definition of healthy status (Exclusion 
criteria) 
Scanning and reporting *Score  
Author, 
year  
n Clearly 
defined 
aim 
Data 
source 
Recruitment 
method 
Defined 
scanning 
protocol 
Defined 
analysis 
protocol 
Number 
of 
readers 
Report 
observer 
variability? 
 
Bulow et 
al., 2018 
634 Yes Subset of 
population-
based study 
(SHIP)* 
Two stage stratified 
cluster sampling and 
random cluster 
sampling (SHIP), 
subset undergoing 
contrast enhanced 
CMR included 
Cardiac disease: MI, HF, stroke, PVD, 
previous cardiac surgery 
CVD risk factors: Hypertension, diabetes 
Non-cardiac disease: Chronic lung disease 
Medication: cardiovascular/pulmonary 
medication 
Clinical assessment: None 
Blood tests: None  
Other investigations: None 
Yes Yes 2 Inter-observer 
variability 
only 
9 
Lei et al., 
2017 
120 Yes Not stated Prospectively 
recruited volunteers 
without known CVD  
Cardiac disease: Any CVD  
CVD risk factors: Hypertension 
Non-cardiac disease: None 
Medication: None 
Clinical assessment: BP >140/90mmHg 
Blood tests: Abnormal full blood count, 
liver/renal function 
Other investigations: Abnormal ECG/echo 
Yes Yes Not 
stated 
Yes 8 
Petersen et 
al., 2017 
800 Yes Subset of 
population-
based study 
(UKB) 
UKB: Postal invite to 
all UK residents aged 
20-69 years old 
(UKB). 
 
This study: first 5,065 
UKB participants to 
undergo CMR 
Cardiac disease: Any CVD  
CVD risk factors: Hypertension, diabetes, 
hyperlipidaemia, current/ex- smoker 
Non-cardiac disease: Respiratory 
haematological, renal, or rheumatological 
disease, malignancy 
Medication: Antihypertensives, lipid-lowering 
drugs, diabetic medications. 
Clinical assessment: Chest pain or dyspnoea, 
BMI ≥30 kg/m2 
Blood tests: None 
Other investigations: None   
Yes Yes 8 Yes 9 
Aquaro et 
al., 2017 
255 Yes Not stated Not stated Cardiac disease: Any CVD  
CVD risk factors: Hypertension, diabetes, 
hyperlipidaemia, smoking, drug use 
Yes Yes Not 
stated 
Yes 8 
 34 
Non-cardiac disease: Any non-cardiac illness 
that may affect cardiac function 
Medication: Antihypertensives, lipid-lowering 
drugs 
Clinical assessment: Abnormal physical 
examination, BP >149/90mmHg, family 
history of genetic disease,  BMI >30 kg/m2 
Blood tests: None 
Other investigations: Abnormal echo/ECG 
Le et al., 
2016 
180 Yes Local 
community 
(general 
population) 
Prospective 
recruitment through 
advertisement in local 
media 
Cardiac disease: Any CVD or cerebrovascular 
disease  
CVD risk factors: None 
Non-cardiac disease: None 
Medication: None 
Clinical assessment: symptoms, family history 
of CVD or cerebrovascular disease 
Blood tests: None 
Other investigations: None 
Yes Yes 2  Inter-observer 
variability 
only 
9 
Li et al., 
2016 
90 Yes Not stated Not stated Cardiac disease: Any CVD   
CVD risk factors: None 
Non-cardiac disease: None 
Medication: Any recent medications 
Clinical assessment: Abnormal BP  (90/60 
mmHg–140/90 
mmHg for systolic–diastolic blood pressure, 
respectively) 
Blood tests: None 
Other investigations: None 
Yes Yes Not 
stated 
Not stated 8 
Le Ven et 
al., 2016 
434 Yes Not stated Phone, email, word-
of-mouth invitation 
Cardiac disease: Any CVD   
CVD risk factors: Obesity, smoking, 
hyperlipidaemia, diabetes 
Non-cardiac disease: None 
Medication: None 
Clinical assessment: None   
Blood tests: Abnormal lipid profile, fasting 
glucose, troponin, Nt-pro-BNP 
Other investigations: None 
Yes Yes 4 Yes 9 
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Yeon et 
al., 2015 
852 Yes Subset of 
population-
based study 
(FHS) 
FHS offspring cohort 
who underwent CMR 
Cardiac disease: MI, HF   
CVD risk factors: Hypertension 
Non-cardiac disease: None 
Medication: Anti-hypertensives 
Clinical assessment: BP >140/90mmHg   
Blood tests: None  
Other investigations: None 
Yes Yes 1 Not stated  9 
Macedo et 
al., 2013 
107 Yes Subset of 
LAC-CMR 
registry 
Brazilian subset of 
LAC-CMR 
registry. Advertised 
on social networks, in 
participating 
universities and, 
private-owned clinics 
of the cities taking 
part in this study. 
Cardiac disease: Any cardiomyopathy 
CVD risk factors: Hypertension, current/ex- 
smoker, diabetes  
Non-cardiac disease: None 
Medication: Anti-hypertensives 
Clinical assessment: BP (systolic > 120 
mmHg or diastolic > 80 mmHg), symptoms, 
abnormal physical examination 
Blood tests: fasting glycemia > 100 mg/dL, 
total cholesterol > 200 mg/dL, abnormal BNP 
Other investigations: Abnormal ECG 
Yes Yes 3 Yes 10 
Chang et 
al., 2012 
124 Yes Not stated Prospective 
recruitment 
Cardiac disease: Any CVD, cerebrovascular 
disease 
CVD risk factors: Hypertension, diabetes 
Non-cardiac disease: None 
Medication: Any regular medications 
Clinical assessment: History of chest pain or 
dyspnoea  
Blood tests: None 
Other investigations: Abnormal echo/ECG 
Yes Yes 1 Yes 8 
Teo et al., 
2008 
60 Yes Not stated Consecutive 
recruitment 
Cardiac disease: Any CVD 
CVD risk factors: Hypertension 
Non-cardiac disease: Respiratory disease 
Medication: Any regular medications 
Clinical assessment: normal BP  
Blood tests: None 
Other investigations: Abnormal echo/ECG  
Yes Yes 1 Yes 8 
Maceira et 
al., 2006 
120 Yes Not stated Not stated Cardiac disease: Any CVD 
CVD risk factors: “Any known risk factors” 
Non-cardiac disease: None 
Medication: None 
Yes Yes Not 
stated 
Not stated 8 
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Clinical assessment:  Symptoms, abnormal 
physical examination 
Blood tests: Abnormal BNP 
Other investigations: Abnormal ECG  
Nikitin et 
al., 2006 
95 Yes Primary 
care 
practice 
lists 
All individuals 
without chronic 
illness, CVD, or 
regular medication 
were invited 
Cardiac disease: Any CVD 
CVD risk factors: Hypertension 
Non-cardiac disease: Any chronic illness 
Medication: None 
Clinical assessment:  Blood pressure  
>160/95, BMI >30kg/m2 
Blood tests: fasting blood glucose >105 mg/dl 
Other investigations:  
Positive treadmill exercise test, Abnormal echo  
Yes Yes Not 
stated 
Not stated  8 
Hudsmith 
et al., 
2005 
108 Yes Not stated Not stated Cardiac disease: Any CVD 
CVD risk factors: Hypertension, “cardiac risk 
factors” 
Non-cardiac disease: None 
Medication: None 
Clinical assessment: None 
Blood tests: None 
Other investigations: Abnormal ECG  
Yes Yes 2 Yes 7 
Alfakih et 
al., 2003 
60 Yes Not stated Not stated  Cardiac disease: Any CVD 
CVD risk factors: diabetes, Hypertension 
Non-cardiac disease: None 
Medication: None 
Clinical assessment: Abnormal cardiac 
examination, abnormal BP 
Blood tests: None 
Other investigations: Abnormal ECG 
Yes Yes 1 Yes 7 
LAC-CMR: The Latin-American, Multi-Centres, reference study of CMR (CMR-LAC Registry) ECG: electrocardiography FHS: Framingham Heart Study; SHIP: Study of Health in 
Pomerania; UKB: United Kingdom Biobank; CVD: cardiovascular disease; MI: myocardial infarction; ICC: intra-class correlation; COV: coefficient of variation; CMR: cardiac magnetic 
resonance; HF: heart failure; PVD: peripheral vascular disease; Nt-ProBNP: N terminal  pro B-Type Natriuretic Peptide; *Max score =10/10 
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Supplementary Table 3. Pooled mean left ventricular parameters stratified by sex and age with expression of 
subgroup heterogeneity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Age group 
(years) 
n* Mean 95% CI subgroup heterogeneity 
      Mean difference               
(20-40 years vs. >65 years) 
Q statistic p-value 
LVEDVi 
(ml/m2) 
Women 20-40 270 79.0 (76.8 – 81.2) 14.0 18.9 8.02×10-5 
 40-65 880 69.7 (64.5 –74.9)   
 >65 318 65.0 (56.9 – 73.2)   
Men 20-40 291 86.2 (82.5 – 89.8) 14.7 13.6 0.0011 
 40-65 727 78.7 (73.4 – 83.9)   
 >65 247 71.5 (63.8 – 79.2)   
LVESVi 
(ml/m2) 
Women 20-40 257 28.7 (26.3–31.1) 6.7 5.0 0.081 
 40-65 863 25.4 (21.3–29.5)    
 >65 318 22.0 (16.0–28.1)    
Men 20-40 278 32.6 (28.5–36.7) 6.7 3.0 0.22 
 40-65 710 30.1 (25.3–35.0)    
 >65 247 25.9 (19.5–32.3)    
LVMi (g/m2) Women 20-40 270 50.2 (44.2–56.2) 1.4 2.7 0.26 
  40-65 880 45.1 (41.5–48.7)    
  >65 318 48.8 (44.0–53.7)    
 Men 20-40 291 64.3 (57.8–70.8) 4.5 1.0 0.60 
  40-65 727 60.9 (56.5–65.3)    
  >65 247 59.8 (53.0–66.6)    
LVEF (%) Women 20-40 270 63.9 (61.0–66.9) -2.7 0.9 0.64 
  40-65 880 63.6 (60.5–66.7)    
  >65 318 66.6 (61.1–72.2)    
 Men 20-40 291 62.4 (58.8–66.0) -2.1 0.5 0.77 
  40-65 727 62.2 (59.0–65.5)    
  >65 247 64.5 (59.0–70.0)    
CI: confidence interval; LVEDVi: left ventricular end diastolic volume indexed to body surface area; LVESVi: left ventricular end 
systolic volume indexed to body surface area; LVMi: left ventricular mass indexed to body surface area; LVEF: left ventricular 
ejection fraction. *n denotes total number of participants in the pool. Results are from the random effects model. 
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Supplementary Table 4. Pooled mean left ventricular parameters with sex and ethnicity stratification and 
expression of subgroup heterogeneity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Ethnicity n Mean  (95% CI)* Subgroup heterogeneity 
     Mean difference Q statistic p-value 
LVEDVi (ml/m2) Women Caucasian 1,825 71.7 (67.2–76.2) 3.2 1.13 0.57 
 East Asian 254 70.8 (69.6–72.0)   
 Brazilian* 53 68.5 (64.3–72.2)    
Men Caucasian 1,576 78.4 (73.5–83.2) 4.2 1.84 0.40 
 East Asian 260 75.6 (71.5–79.7)   
  Brazilian 54 74.2 (70.1–78.4)    
LVESVi (ml/m2) Women Caucasian 1776 24.5 (21.4– 27.7) 0.5 0.06 0.97 
 East Asian 254 24.2 (22.5–26.0)    
 Brazilian 53 24.0 (21.4–27.6)    
Men Caucasian 1,576 29.1 (25.2–33.0) 2.8 1.61 0.45 
 East Asian 260 27.4 (23.0–31.9)    
  Brazilian 54 26.3 (24.5–28.7)    
LVMi (g/m2) Women Caucasian 1,825 50.6 (47.2–54.0) 6.4 8.37 0.015 
  East Asian 254 44.2 (40.3–48.1)    
  Brazilian 53 44.6 (40.5–48.5)    
 Men Caucasian 1,576 63.4 (59.3–67.4) 9.8 18.76 8.44 ×10-5 
  East Asian 260 53.6 (51.0–56.2)    
  Brazilian 54 59.8 (55.6–63.2)    
LVEF (%) Women Caucasian 1,825 65.0 (62.5–67.5) 1.1 0.5 0.78 
  East Asian 254 65.6 (63.0–68.2)    
  Brazilian 53 66.1 (64.9–68.6)    
 Men Caucasian 1,576 63.8 (60.9–66.7) 1.3 0.62 0.73 
  East Asian 260 63.6 (59.3–67.9)    
  Brazilian 54 64.9 (63.0–66.7)    
CI: confidence interval; LVEDVi: left ventricular end-diastolic volume indexed to body surface area (ml/m2); LVESVi: left 
ventricular end-systolic volume indexed to body surface area (ml/m2); LVMi: left ventricular mass indexed to body surface 
area (g/m2); LVEF: left ventricular ejection fraction (%). Random effects estimates are presented. Asian refers to Chinese, 
Singaporean-Chinese, and Korean ethnicity. *The Brazilian cohort is from a single study and does not represent pooled 
analysis, the authors do not explicitly state ethnicity- hence we have labelled results here as “Brazilian”.  
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Supplementary Table 5. Sensitivity analysis for LV parameters according to scanner vendor, field strength, post-processing software, and papillary 
muscle contouring 
 
 
 
 
 
 
 
 Sensitivity analyses for between group differences* 
  Scanner vendor Magnet strength Post-processing 
software 
Contouring 
methodology 
Age Ethnicity 
  Q p-value Q p-value Q p-value Q p-value Q p-value Q p-value 
LVEDVi 
(ml/m2) 
Men 0.44 0.51 0.47 0.49 5.01 0.29 0.19 0.67 13.62  0.0011 0.73 0.39 
Women 0.28 0.60 0.22 0.64 1.80 0.77 0.43 0.51 18.86 8.02×10-5 0.15 0.69 
LVESVi 
(ml/m2) 
Men 0.44 0.51 0.03 0.86 27.36 1.14×10-6 0.85 0.36 3.01 0.22 0.3 0.58 
Women 0.7 0.40 0.01 0.94 10.87 0.012 0.2 0.66 5.04 0.081 0.03 0.86 
LVMi 
(g/m2) 
Men 0.28 0.60 26.55 2.6 ×10-7 183.48 1.6×10-39 5.71 0.017 1.02 0.60 15.88 6.7×10-5 
Women 1.03 0.31 4.28 0.039 8.09 0.044 4.77 0.029 2.68 0.26 5.85 0.016 
LVEF 
(%) 
Men 0.45 0.50 0.07 0.80 6.49 0.17 1.41 0.23 0.53 0.77 0 0.95 
Women 0.71 0.40 0.02 0.89 6.51 0.16 0.53 0.47 0.91 0.64 0.1 0.75 
*scanner vendor (Siemens, Philips), field strength (1.5T, 3T), post-processing software [CMR42 (Circle Cardiovascular imaging, Qmass (Medis), MRI-mass 
(Medis), Argus(Siemens)], and contouring methodology (papillary muscles included vs excluded from LVM). CI: confidence interval; LVEDVi: left 
ventricular end diastolic volume indexed to body surface area (ml/m2); LVESVi: left ventricular end systolic volume indexed to body surface area (ml/m2); 
LVMi: left ventricular mass indexed to body surface area (g/m2); LVEF: left ventricular ejection fraction (%). Results are based on random effects estimates. 
significance level is set at p-value <0.05. 
 
